Source: International Immunopharmacology. Unidades: ESALQ, ICB
Subjects: ANTI-INFLAMATÓRIOS, CITOCINAS, MICROBIOLOGIA, PRÓPOLIS, MACRÓFAGOS, FENÓTIPOS, INFLAMAÇÃO, PRODUTOS NATURAIS, NEUTRÓFILOS, EXPRESSÃO GÊNICA, ÓXIDO NÍTRICO
ABNT
BUENO-SILVA, Bruno et al. Vestitol drives LPS-activated macrophages into M2 phenotype through modulation of NF-κB pathway. International Immunopharmacology, v. 82, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.intimp.2020.106329. Acesso em: 16 out. 2024.APA
Bueno-Silva, B., Rosalen, P. L., Alencar, S. M., & Mayer, M. P. A. (2020). Vestitol drives LPS-activated macrophages into M2 phenotype through modulation of NF-κB pathway. International Immunopharmacology, 82, 1-7. doi:10.1016/j.intimp.2020.106329NLM
Bueno-Silva B, Rosalen PL, Alencar SM, Mayer MPA. Vestitol drives LPS-activated macrophages into M2 phenotype through modulation of NF-κB pathway [Internet]. International Immunopharmacology. 2020 ; 82 1-7.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.intimp.2020.106329Vancouver
Bueno-Silva B, Rosalen PL, Alencar SM, Mayer MPA. Vestitol drives LPS-activated macrophages into M2 phenotype through modulation of NF-κB pathway [Internet]. International Immunopharmacology. 2020 ; 82 1-7.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.intimp.2020.106329